In tackling high drug prices, FTC shows partisan split
Combating unreasonable, unilateral drug price hikes is a big talking point on the presidential campaign trail. But when lawmakers asked the Federal Trade Commission about whether it could help, the commissioners...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content